176 related articles for article (PubMed ID: 33743547)
1. Ppp6c haploinsufficiency accelerates UV-induced BRAF(V600E)-initiated melanomagenesis.
Kanazawa K; Kishimoto K; Nomura M; Kurosawa K; Kato H; Inoue Y; Miura K; Fukui K; Yamashita Y; Sato I; Tsuji H; Watanabe T; Tanaka T; Yasuda J; Tanuma N; Shima H
Cancer Sci; 2021 Jun; 112(6):2233-2244. PubMed ID: 33743547
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.
Viros A; Sanchez-Laorden B; Pedersen M; Furney SJ; Rae J; Hogan K; Ejiama S; Girotti MR; Cook M; Dhomen N; Marais R
Nature; 2014 Jul; 511(7510):478-482. PubMed ID: 24919155
[TBL] [Abstract][Full Text] [Related]
3. Loss of protein phosphatase 6 in mouse keratinocytes increases susceptibility to ultraviolet-B-induced carcinogenesis.
Kato H; Kurosawa K; Inoue Y; Tanuma N; Momoi Y; Hayashi K; Ogoh H; Nomura M; Sakayori M; Kakugawa Y; Yamashita Y; Miura K; Maemondo M; Katakura R; Ito S; Sato M; Sato I; Chiba N; Watanabe T; Shima H
Cancer Lett; 2015 Sep; 365(2):223-8. PubMed ID: 26054846
[TBL] [Abstract][Full Text] [Related]
4. PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features.
Fukui K; Nomura M; Kishimoto K; Tanuma N; Kurosawa K; Kanazawa K; Kato H; Sato T; Miura S; Miura K; Sato I; Tsuji H; Yamashita Y; Tamai K; Watanabe T; Yasuda J; Tanaka T; Satoh K; Furukawa T; Jingu K; Shima H
Cancer Sci; 2022 May; 113(5):1613-1624. PubMed ID: 35247012
[TBL] [Abstract][Full Text] [Related]
5. PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity.
Maskin CR; Raman R; Houvras Y
Sci Rep; 2022 Apr; 12(1):5573. PubMed ID: 35368039
[TBL] [Abstract][Full Text] [Related]
6. Ppp6c deficiency accelerates K-ras
Kishimoto K; Kanazawa K; Nomura M; Tanaka T; Shigemoto-Kuroda T; Fukui K; Miura K; Kurosawa K; Kawai M; Kato H; Terasaki K; Sakamoto Y; Yamashita Y; Sato I; Tanuma N; Tamai K; Kitabayashi I; Matsuura K; Watanabe T; Yasuda J; Tsuji H; Shima H
Cancer Med; 2021 Jul; 10(13):4451-4464. PubMed ID: 34145991
[TBL] [Abstract][Full Text] [Related]
7. KIT Suppresses BRAF
Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
[TBL] [Abstract][Full Text] [Related]
8. UV and melanoma: the TP53 link.
Choi YS; Fisher DE
Cell Res; 2014 Oct; 24(10):1157-8. PubMed ID: 25033756
[TBL] [Abstract][Full Text] [Related]
9. Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.
Luo C; Sheng J; Hu MG; Haluska FG; Cui R; Xu Z; Tsichlis PN; Hu GF; Hinds PW
Cancer Res; 2013 Jul; 73(14):4337-48. PubMed ID: 23650282
[TBL] [Abstract][Full Text] [Related]
10. Telomere dysfunction in Tert knockout mice delays Braf
Zhang J; Zhang F; Porter KI; Dakup PP; Wang S; Robertson GP; Gaddameedhi S; Zhu J
Int J Cancer; 2024 Feb; 154(3):548-560. PubMed ID: 37727982
[TBL] [Abstract][Full Text] [Related]
11. UVB mutagenesis differs in
Bowman RL; Hennessey RC; Weiss TJ; Tallman DA; Crawford ER; Murphy BM; Webb A; Zhang S; La Perle KM; Burd CJ; Levine RL; Shain AH; Burd CE
Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34210801
[No Abstract] [Full Text] [Related]
12. Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA.
Hayashi K; Momoi Y; Tanuma N; Kishimoto A; Ogoh H; Kato H; Suzuki M; Sakamoto Y; Inoue Y; Nomura M; Kiyonari H; Sakayori M; Fukamachi K; Kakugawa Y; Yamashita Y; Ito S; Sato I; Suzuki A; Nishio M; Suganuma M; Watanabe T; Shima H
Oncogene; 2015 Aug; 34(35):4647-55. PubMed ID: 25486434
[TBL] [Abstract][Full Text] [Related]
13. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic BRAF
Shabaneh TB; Molodtsov AK; Steinberg SM; Zhang P; Torres GM; Mohamed GA; Boni A; Curiel TJ; Angeles CV; Turk MJ
Cancer Res; 2018 Sep; 78(17):5038-5049. PubMed ID: 30026331
[TBL] [Abstract][Full Text] [Related]
16. A landscape of driver mutations in melanoma.
Hodis E; Watson IR; Kryukov GV; Arold ST; Imielinski M; Theurillat JP; Nickerson E; Auclair D; Li L; Place C; Dicara D; Ramos AH; Lawrence MS; Cibulskis K; Sivachenko A; Voet D; Saksena G; Stransky N; Onofrio RC; Winckler W; Ardlie K; Wagle N; Wargo J; Chong K; Morton DL; Stemke-Hale K; Chen G; Noble M; Meyerson M; Ladbury JE; Davies MA; Gershenwald JE; Wagner SN; Hoon DS; Schadendorf D; Lander ES; Gabriel SB; Getz G; Garraway LA; Chin L
Cell; 2012 Jul; 150(2):251-63. PubMed ID: 22817889
[TBL] [Abstract][Full Text] [Related]
17. BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage.
Mar VJ; Wong SQ; Li J; Scolyer RA; McLean C; Papenfuss AT; Tothill RW; Kakavand H; Mann GJ; Thompson JF; Behren A; Cebon JS; Wolfe R; Kelly JW; Dobrovic A; McArthur GA
Clin Cancer Res; 2013 Sep; 19(17):4589-98. PubMed ID: 23833303
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-associated mutations in protein phosphatase 6 cause chromosome instability and DNA damage owing to dysregulated Aurora-A.
Hammond D; Zeng K; Espert A; Bastos RN; Baron RD; Gruneberg U; Barr FA
J Cell Sci; 2013 Aug; 126(Pt 15):3429-40. PubMed ID: 23729733
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
